We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.
axialHealthcare Closes Series C Funding Round
You Also May Be Interested In:
Representation of Spring Fertility, a premier provider of fertility care in the United States backed by Wildcat Capital, in its acquisition of Genesis Fertility Centre, a Vancouver, British Columbia-based fertility clinic
Representation of Merchants & Marine Bancorp, Inc., a full-service state-chartered community bank with 13 branch offices across the Mississippi and Alabama Gulf Coast, in its definitive agreement to acquire the Mobile, Alabama branch of Bank OZK (Nasdaq: OZK